Nomura Research Institute (NRILY)
(Delayed Data from OTC)
$34.76 USD
+0.18 (0.52%)
Updated Oct 4, 2024 03:59 PM ET
1-Strong Buy of 5 1
D Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Nomura Research Institute falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 808.85 | 802.89 | 931.57 | 642.00 | 941.97 |
Depreciation/Amortization & Depletion | 332.28 | 333.68 | 373.27 | 369.53 | 279.52 |
Net Change from Assets/Liabilities | -22.61 | -0.01 | -213.65 | -127.68 | -56.04 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -136.82 | -256.71 | -217.77 | -119.75 | -220.81 |
Net Cash From Operating Activities | 981.71 | 879.85 | 873.42 | 764.10 | 944.65 |
Property & Equipment | -51.34 | -38.14 | 31.65 | -68.91 | -45.70 |
Acquisition/ Disposition of Subsidiaries | -28.09 | -64.97 | -668.43 | 0.00 | 2.09 |
Investments | -0.68 | -26.09 | -54.17 | 77.15 | 416.66 |
Other Investing Activities | -288.50 | -323.60 | -470.90 | -193.61 | -204.11 |
Net Cash from Investing Activities | -368.61 | -452.81 | -1,161.87 | -185.38 | 168.94 |
Uses of Funds
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -437.41 | 18.99 | -475.14 | 156.99 | -1,508.38 |
Issuance (Repayment) of Debt | -18.02 | 204.04 | -150.29 | -133.76 | 42.55 |
Increase (Decrease) Short-Term Debt | 322.24 | -219.68 | 755.82 | 99.10 | 361.72 |
Payment of Dividends & Other Distributions | -191.24 | -187.75 | -201.56 | -184.08 | -181.22 |
Other Financing Activities | -3.83 | -148.00 | 0.00 | -57.32 | -1.11 |
Net Cash from Financing Activities | -328.27 | -332.42 | -71.16 | -119.08 | -1,285.33 |
Effect of Exchange Rate Changes | 23.45 | 6.36 | 25.18 | 13.74 | -34.32 |
Net Change In Cash & Equivalents | 308.28 | 100.98 | -334.43 | 473.39 | -206.07 |
Cash at Beginning of Period | 891.87 | 855.51 | 1,363.36 | 910.30 | 1,132.26 |
Cash at End of Period | 1,200.15 | 956.50 | 1,028.93 | 1,383.69 | 926.19 |
Diluted Net EPS | 0.90 | 0.95 | 1.07 | 0.80 | 4.11 |
Fiscal Year End for Nomura Research Institute falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 808.85 | 607.06 | 397.02 | 194.03 |
Depreciation/Amortization & Depletion | NA | 332.28 | 245.19 | 163.89 | 85.55 |
Net Change from Assets/Liabilities | NA | -22.61 | -122.32 | -68.48 | 9.80 |
Net Cash from Discontinued Operations | NA | 0.00 | NA | NA | 0.00 |
Other Operating Activities | NA | -136.82 | -51.78 | -23.19 | 28.11 |
Net Cash From Operating Activities | NA | 981.71 | 678.16 | 469.24 | 317.48 |
Property & Equipment | NA | -51.34 | -42.86 | -31.04 | -27.72 |
Acquisition/ Disposition of Subsidiaries | NA | -28.09 | -27.45 | -27.55 | 0.00 |
Investments | NA | -0.68 | -0.41 | -0.01 | -0.01 |
Other Investing Activities | NA | -288.50 | -222.48 | -156.19 | -88.18 |
Net Cash from Investing Activities | NA | -368.61 | -293.20 | -214.78 | -115.91 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -437.41 | -443.67 | -309.69 | -123.74 |
Issuance (Repayment) of Debt | NA | -18.02 | 15.26 | 51.28 | 85.47 |
Increase (Decrease) Short-Term Debt | NA | 322.24 | 324.27 | 56.13 | -13.41 |
Payment of Dividends & Other Distributions | NA | -191.24 | -188.46 | -95.08 | -99.83 |
Other Financing Activities | NA | -3.83 | -3.77 | -3.83 | -5.02 |
Net Cash from Financing Activities | NA | -328.27 | -296.38 | -301.19 | -156.54 |
Effect of Exchange Rate Changes | NA | 23.45 | 13.76 | 18.80 | 14.02 |
Net Change In Cash & Equivalents | NA | 308.28 | 102.32 | -27.93 | 59.06 |
Cash at Beginning of Period | NA | 891.87 | 878.95 | 891.87 | 943.58 |
Cash at End of Period | NA | 1,200.15 | 981.27 | 863.94 | 1,002.63 |
Diluted Net EPS | 0.25 | 0.22 | 0.27 | 0.24 | 0.21 |